Looking for penny stocks that could potentially bring massive returns in the upcoming years? Here are three penny stocks with significant growth potential heading into 2025.
Penny stocks are stocks valued at less than $5, making them some of the most affordable investments on the market. While these stocks can be highly profitable, they also come with high risk due to their low prices and the uncertainty surrounding their growth potential. However, there are exceptions to this rule.
One such exception is 23andME (ME), a DNA testing-based service that allows customers to trace their heritage by submitting a small DNA sample. Despite a significant drop in stock value in recent years, many investors still believe in the comeback potential of 23andME. The company’s ability to sell DNA samples to pharmaceutical companies, such as GSK, along with its own drug development efforts, could lead to significant growth in the near future.
Vigil Neuroscience (VIGL) is another penny stock to watch, particularly in the biotech sector. The company is developing treatments for neurodegenerative diseases, with promising results from its phase 2 trials for the Iluzanebart treatment. Additionally, Vigil is working on an Alzheimer’s treatment called VGL-3927, further adding to its growth potential.
Savara (SVRA) is yet another penny stock making waves in the biopharma industry. The company is focused on developing treatments for respiratory diseases, with its lead candidate, molgramostim, showing positive results in phase 3 trials. Savara has also received FDA designations for its treatments, showcasing their potential for future growth.
While penny stocks can be risky investments, these three stocks have shown significant growth potential and exciting developments that could lead to substantial returns for investors. It’s important to stay informed about the latest updates from these companies to make informed investment decisions.